Balyasny Asset Management
AYLA

Balyasny Asset Management’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Balyasny Asset Management’s Portfolio AYLA Stock Details AYLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-23,761
Closed -$24K – 3405
2022
Q3 		$24K Buy
+23,761
New +$32K ﹤0.01% 2565

Other funds holding AYLA

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Balyasny Asset Management's AYLA Position: Q4 2022 in Review

Balyasny Asset Management sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q4 2022, closing a stake of 23,761 shares — an estimated $24K sold.

Balyasny Asset Management first reported a position in AYLA in Q3 2022 and held it in 1 quarter. The position peaked at $24K in Q3 2022. 11 funds tracked by Wall St. Rank hold AYLA as of Q4 2022.

  • Balyasny Asset Management reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 23,761 Ayala Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $24K.
  • Balyasny Asset Management first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Balyasny Asset Management's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $24K in Q3 2022.
  • 11 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.